APA

Finke P. E., Shah S. K., Fletcher D. S., Ashe B. M., Brause K. A., Chandler G. O., Dellea P. S., Hand K. M., Maycock A. L. & Osinga D. G. (19950817). Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones. : Journal of medicinal chemistry.

Chicago

Finke P E, Shah S K, Fletcher D S, Ashe B M, Brause K A, Chandler G O, Dellea P S, Hand K M, Maycock A L and Osinga D G. 19950817. Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones. : Journal of medicinal chemistry.

Harvard

Finke P. E., Shah S. K., Fletcher D. S., Ashe B. M., Brause K. A., Chandler G. O., Dellea P. S., Hand K. M., Maycock A. L. and Osinga D. G. (19950817). Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones. : Journal of medicinal chemistry.

MLA

Finke P E, Shah S K, Fletcher D S, Ashe B M, Brause K A, Chandler G O, Dellea P S, Hand K M, Maycock A L and Osinga D G. Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones. : Journal of medicinal chemistry. 19950817.